Compare MXCT & FTLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MXCT | FTLF |
|---|---|---|
| Founded | 1999 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 129.6M | 134.1M |
| IPO Year | 2021 | 2006 |
| Metric | MXCT | FTLF |
|---|---|---|
| Price | $1.18 | $9.58 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | $5.50 | ★ $21.50 |
| AVG Volume (30 Days) | ★ 1.3M | 29.7K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.17 |
| Revenue | ★ $33,026,000.00 | $21,744,000.00 |
| Revenue This Year | N/A | $45.76 |
| Revenue Next Year | $18.50 | $5.10 |
| P/E Ratio | ★ N/A | $58.82 |
| Revenue Growth | N/A | ★ 11.52 |
| 52 Week Low | $0.64 | $8.67 |
| 52 Week High | $2.38 | $20.98 |
| Indicator | MXCT | FTLF |
|---|---|---|
| Relative Strength Index (RSI) | 64.09 | 45.00 |
| Support Level | $0.77 | $8.98 |
| Resistance Level | $1.82 | $9.87 |
| Average True Range (ATR) | 0.09 | 0.86 |
| MACD | 0.01 | 0.02 |
| Stochastic Oscillator | 60.00 | 16.87 |
MaxCyte Inc is a life sciences company focused on advancing the discovery, development, and commercialization of next-generation cell therapies. It uses its proprietary cell engineering technology platform to support biotechnology and pharmaceutical customers in cell therapy, gene editing, immuno-oncology, and biologic development. It operates in one segment: cell engineering technology, which generates revenue mainly from product sales, licenses, research and clinical license fees, and program-related revenues as its SPL customers achieve development and regulatory milestones. Its platform, the ExPERT Platform, is based on Flow Electroporation technology designed to efficiently and safely modify human cells with high efficiency, low cytotoxicity, and scalability for clinical use.
FitLife Brands Inc is a provider of proprietary nutritional supplements for health-conscious consumers. The company markets and sells its products under NDS, PMD, Siren labs, Core active, Metis nutrition, Isatori, and Biogenetic laboratories brand names. Its product portfolio consists of sports nutrition, energy, sports drink products, meal replacement products, and weight loss products. The firm derives its revenue from product sales. Its product categories include Natural & Organic Foods, Functional Foods, Natural & Organic Personal Care and Household Products, and Supplements.